Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients
BackgroundEnd-stage kidney disease substantially increases the risk of severe COVID-19. However, despite early robust immunogenicity of the mRNA-SARS-CoV-2 vaccination in patients with hemodialysis, the longevity of humoral response in this high-risk population is still unknown.MethodsA prospective...
Shranjeno v:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2022-03-01
|
| Serija: | Frontiers in Medicine |
| Teme: | |
| Online dostop: | https://www.frontiersin.org/articles/10.3389/fmed.2022.781888/full |
| Oznake: |
Brez oznak, prvi označite!
|